Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 2022

View Archived Issues

Enanta Pharmaceuticals patents Mpro inhibitors for coronovirus infections

Gilead Sciences describes GLP-1 receptor agonists

New SERD inducers disclosed for treatment of cancer

Lundbeck divulges catecholamine prodrugs for Parkinson's disease

Exscientia describes MALT1 inhibitors

Adropin as novel therapeutic target to attenuate fibroblast activation and fibrosis in SSc

New in vitro data support advancing SLS-004 for dementia with Lewy bodies

Washington University extends research of Hoth's HT-ALZ in mouse model of Alzheimer's disease

Circulating miRNAs associated with difficult-to-treat RA

Novel humanized mouse model of rheumatoid arthritis

Circuit, synuclein insights reported in Parkinson's disease

Senti Biosciences outlines plans for gene circuit technologies and therapeutic pipeline

Advisory board reviews preclinical data for fourth-generation EGFR TKI JIN-A02

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...